A global view on the development of non communicable diseases
KH Wagner, H Brath - Preventive medicine, 2012 - Elsevier
For a long time non communicable diseases (NCDs) were discussed as burden of the
developed world. Recent alarming data show a reverse trend and a dramatic increase of …
developed world. Recent alarming data show a reverse trend and a dramatic increase of …
Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity
M Remely, E Aumueller, C Merold, S Dworzak, B Hippe… - Gene, 2014 - Elsevier
The human gut microbiota and microbial influences on lipid and glucose metabolism,
satiety, and chronic low-grade inflammation are known to be involved in metabolic …
satiety, and chronic low-grade inflammation are known to be involved in metabolic …
PONTIAC (NT-proBNP Selected PreventiOn of cardiac events in a populaTion of dIabetic patients without A history of Cardiac disease) A Prospective Randomized …
M Huelsmann, S Neuhold, M Resl, G Strunk… - Journal of the American …, 2013 - jacc.org
Objectives: The study sought to assess the primary preventive effect of neurohumoral
therapy in high-risk diabetic patients selected by N-terminal pro–B-type natriuretic peptide …
therapy in high-risk diabetic patients selected by N-terminal pro–B-type natriuretic peptide …
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 …
T Danne, B Cariou, P Banks, M Brandle, H Brath… - Diabetes …, 2018 - Am Diabetes Assoc
OBJECTIVE The objective of this study was to evaluate the efficacy and safety of the dual
sodium–glucose cotransporter 1 and 2 inhibitor sotagliflozin compared with placebo when …
sodium–glucose cotransporter 1 and 2 inhibitor sotagliflozin compared with placebo when …
Mobile health (mHealth) based medication adherence measurement–a pilot trial using electronic blisters in diabetes patients
H Brath, J Morak, T Kästenbauer… - British journal of …, 2013 - Wiley Online Library
Aims The aim of the present study was to evaluate a mobile health (mHealth) based remote
medication adherence measurement system (mAMS) in elderly patients with increased …
medication adherence measurement system (mAMS) in elderly patients with increased …
Effects of smoking cessation on β-cell function, insulin sensitivity, body weight, and appetite
M Stadler, L Tomann, A Storka, M Wolzt… - European journal of …, 2014 - academic.oup.com
Objective To stop smoking is commonly associated with significant weight gain, but the
mechanisms for this are poorly understood. We assessed the effects of smoking cessation …
mechanisms for this are poorly understood. We assessed the effects of smoking cessation …
[HTML][HTML] Oxidative stress, DNA damage and DNA repair in female patients with diabetes mellitus type 2
A Grindel, B Guggenberger, L Eichberger… - PloS one, 2016 - journals.plos.org
Background Diabetes mellitus type 2 (T2DM) is associated with oxidative stress which in
turn can lead to DNA damage. The aim of the present study was to analyze oxidative stress …
turn can lead to DNA damage. The aim of the present study was to analyze oxidative stress …
Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with type 2 diabetes …
J Harreiter, I Just, M Leutner, M Bastian… - Diabetes, Obesity …, 2021 - Wiley Online Library
Aims To investigate the potential synergistic effects of combined exenatide (EXE) and
dapagliflozin (DAPA) versus (PLAC) placebo and DAPA on hepatocellular lipid (HCL) …
dapagliflozin (DAPA) versus (PLAC) placebo and DAPA on hepatocellular lipid (HCL) …
Gallic acid improves health‐associated biochemical parameters and prevents oxidative damage of DNA in type 2 diabetes patients: Results of a placebo‐controlled …
F Ferk, M Kundi, H Brath, T Szekeres… - Molecular nutrition & …, 2018 - Wiley Online Library
Scope Oxidative imbalance plays a key role in cancer induction and cardiovascular
diseases (CVD) in patients with type 2 diabetes mellitus (T2DM). The aim of this study is to …
diseases (CVD) in patients with type 2 diabetes mellitus (T2DM). The aim of this study is to …
[PDF][PDF] Abundance and diversity of microbiota in type 2 diabetes and obesity
M Remely, S Dworzak, B Hippe, J Zwielehner… - J Diabetes …, 2013 - academia.edu
Inlammatory reactions leading to the progression of metabolic syndrome contribute to
changes in composition of the GIT microbiota. We characterize fecal microbiota at three time …
changes in composition of the GIT microbiota. We characterize fecal microbiota at three time …